Tempest Therapeutics, Inc. (TPST)

NASDAQ: TPST · IEX Real-Time Price · USD

2.120

-0.020 (-0.93%)

At close: Jul 2, 2024, 4:00 PM

2.090

-0.030 (-1.42%)

After-hours: Jul 2, 2024, 7:59 PM EDT

Tempest Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2012
Net Income	-29.49	-35.71	-28.3	-19.21	-44.57	Upgrade
Depreciation & Amortization	2.08	1.81	1.27	0.82	1.05	Upgrade
Share-Based Compensation	2.55	1.56	1.11	0.45	4.32	Upgrade
Other Operating Activities	-2.49	1.26	-0.03	-1.08	-2.02	Upgrade
Operating Cash Flow	-27.36	-31.07	-25.96	-19.02	-41.22	Upgrade
Capital Expenditures	-0.17	-0.56	-0.14	-0.05	-0.4	Upgrade
Change in Investments	0	0	0.04	0.04	4.39	Upgrade
Investing Cash Flow	-0.17	-0.56	-0.1	-0.01	3.99	Upgrade
Share Issuance / Repurchase	35.6	16.14	44.16	0.07	27.15	Upgrade
Debt Issued / Paid	0	-4.74	15	0	-0.2	Upgrade
Other Financing Activities	-	-	-0.1	34.53	-	Upgrade
Financing Cash Flow	35.6	11.4	59.06	34.6	26.94	Upgrade
Exchange Rate Effect	0	0	0	0	0.03	Upgrade
Net Cash Flow	8.08	-20.23	33.01	15.58	-10.26	Upgrade
Free Cash Flow	-27.53	-31.63	-26.09	-19.07	-41.62	Upgrade
Free Cash Flow Per Share	-1.79	-2.74	-6.88	-40.73	-45.55	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).